Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia

GLIA

Volumn 49, Issue 4, 2005, Pages 567-576

  Kielian, Tammy ^a   Esen, Nilufer ^a   Bearden, Edward D ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Microglia; PGN; S. aureus; Toll like receptor 2

Indexed keywords

INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDOGLYCAN; PROTEIN P40; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; GRAM POSITIVE BACTERIUM; IMMUNE RESPONSE; INNATE IMMUNITY; KNOCKOUT MOUSE; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; BRAIN ABSCESS; CELLS, CULTURED; CYTOKINES; MICE; MICE, KNOCKOUT; MICROGLIA; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDOGLYCAN; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOKINE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2;

EID: 14844348476     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20144     Document Type: Article

References (40)

1. Akira S. 2003. Toll-like receptor signaling. J Biol Chem 278:38105-38108.
2. Aloisi F. 2001. Immune function of microglia. Glia 36:165-179.
3. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021.
4. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. 1996. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 64:1906-1912.
5. Dalpke AH, Schafer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, Heeg K. 2002. Immunostimulatory CpG-DNA activates murine microglia. J Immunol 168:4854-4863.
6. Dziarski R. 2003. Recognition of bacterial peptidoglycan by the innate immune system. Cell Mol Life Sci 60:1793-1804.
7. East L, Isacke CM. 2002. The mannose receptor family. Biochim Biophys Acta 1572:364-386.
8. Esen N, Tanga FY, DeLeo JA, Kielian T. 2004. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J Neurochem 88:746-758.
9. Gordon S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927-930.
10. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40:140-155.
11. Henneke P, Takeuchi O, van Strijp JA, Guttormsen HK, Smith JA, Schromm AB, Espevik TA, Akira S, Nizet V, Kasper DL, Golenbock DT. 2001. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J Immunol 167:7069-7076.
12. Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT. 2002. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 169:3970-3977.
13. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC. 2002. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195-205.
14. Kielian T, Barry B, Hickey WT. 2001. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol 166:4634-4643.
15. Kielian T, Mayes P, Kielian M. 2002. Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J Neuroimmunol 130:86-99.
16. Kielian T, Bearden ED, Baldwin AC, Esen N. 2004a. IL-1 and TNF-alpha play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuropathol Exp Neurol 63:381-396.
17. Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. 2004b. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2). J Neurochem 90:1163-1172.
18. Kopp E, Medzhitov R. 2003. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 15:396-401.
19. Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med 182:1673-1682.
20. Laflamme N, Soucy G, Rivest S. 2001. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem 79:648-657.
21. Laflamme N, Echchannaoui H, Landmann R, Rivest S. 2003. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from grain-negative and gram-positive bacteria. Eur J Immunol 33:1127-1138.
22. Marzolo MP, von Bernhardi R, Inestrosa NC. 1999. Mannose receptor is present in a functional state in rat microglial cells. J Neurosci Res 58:387-395.
23. Mathisen GE, Johnson JP. 1997. Brain abscess. Clin Infect Dis 25: 763-779.
24. Medzhitov R, Janeway C, Jr. 2000. Innate immunity. N Engl J Med 343:338-344.
25. Morath S, Stadelmaier A, Geyer A, Schmidt RR, Hartung T. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med 195:1635-1640.
26. Nadeau S, Rivest S. 2000. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J Neurosci 20:3456-3468.
27. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97:13766-13771.
28. Peiser L, Gough PJ, Kodama T, Gordon S. 2000. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun 68:1953-1963.
29. Peiser L, Mukhopadhyay S, Gordon S. 2002. Scavenger receptors in innate immunity. Curr Opin Immunol 14:123-128.
30. Qureshi ST, Medzhitov R. 2003. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun 4:87-94.
31. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol 21:335-376.
32. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
33. Takeuchi O, Hoshino K, Akira S. 2000a. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392-5396.
34. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S. 2000b. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 12:113-117.
35. Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, El Khoury J. 2000. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med 191:147-156.
36. Townsend GC, Scheid WM. 1998. Infections of the central nervous system. Adv Intern Med 43:403-447.
37. Underhill D, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815.
38. Weber JR, Moreillon P, Tuomanen EI. 2003. Innate sensors for Gram-positive bacteria. Curr Opin Immunol 15:408-415.
39. Weidemann B, Brade H, Rietschel ET, Dziarski R, Bazil V, Kusumoto S, Flad HD, Ulmer AJ. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 62:4709-4715.
40. Zekki H, Feinstein DL, Rivest S. 2002. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol 12:308-319.